Sparano JA - Search Results

1

Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study.

Rajdev L, Jackie Wang CC, Joshi H, Lensing S, Lee J, Ramos JC, Baiocchi R, Ratner L, Rubinstein PG, Ambinder R, Henry D, Streicher H, Little RF, Chiao E, Dittmer DP, Einstein MH, Cesarman E, Mitsuyasu R, Sparano JA; AIDS Malignancy Consortium. Rajdev L, et al. Among authors: sparano ja. Cancer. 2024 Mar 15;130(6):985-994. doi: 10.1002/cncr.35110. Epub 2023 Nov 14. Cancer. 2024. PMID: 37962072

2

Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.

Sparano JA, Hu X, Wiernik PH, Sarta C, Reddy DM, Hanau L, Henry DH. Sparano JA, et al. J Natl Cancer Inst. 1997 Feb 19;89(4):301-7. doi: 10.1093/jnci/89.4.301. J Natl Cancer Inst. 1997. PMID: 9048834

3

Saquinavir enhances the mucosal toxicity of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma.

Sparano JA, Wiernik PH, Hu X, Sarta C, Henry DH, Ratech H. Sparano JA, et al. Med Oncol. 1998 Apr;15(1):50-7. doi: 10.1007/BF02787345. Med Oncol. 1998. PMID: 9643531 Clinical Trial.

4

Patterns of central nervous system recurrence in patients with systemic human immunodeficiency virus-associated non-hodgkin lymphoma.

Desai J, Mitnick RJ, Henry DH, Llena J, Sparano JA. Desai J, et al. Among authors: sparano ja. Cancer. 1999 Nov 1;86(9):1840-7. Cancer. 1999. PMID: 10547559

5

Taxane-based therapy for breast cancer: combination or sequential therapy?

Sparano JA, Rajdev L. Sparano JA, et al. Cancer Invest. 2000;18(5):498-500. doi: 10.3109/07357900009032823. Cancer Invest. 2000. PMID: 10834036 No abstract available.

6

Primary central nervous system lymphoma.

Ambinder RF, Sparano JA. Ambinder RF, et al. Among authors: sparano ja. Cancer Treat Res. 2001;104:231-46. doi: 10.1007/978-1-4615-1601-9_8. Cancer Treat Res. 2001. PMID: 11191129 Review. No abstract available.

7

Phase I trial of pegylated liposomal doxorubicin and docetaxel in advanced breast cancer.

Sparano JA, Malik U, Rajdev L, Sarta C, Hopkins U, Wolff AC. Sparano JA, et al. J Clin Oncol. 2001 Jun 15;19(12):3117-25. doi: 10.1200/JCO.2001.19.12.3117. J Clin Oncol. 2001. PMID: 11408509 Clinical Trial.

8

Phase II study of weekly docetaxel alone or in combination with trastuzumab in patients with metastatic breast cancer.

Raff JP, Rajdev L, Malik U, Novik Y, Manalo JM, Negassa A, Hopkins U, Sarta C, Sparano JA. Raff JP, et al. Among authors: sparano ja. Clin Breast Cancer. 2004 Feb;4(6):420-7. doi: 10.3816/cbc.2004.n.005. Clin Breast Cancer. 2004. PMID: 15023243 Clinical Trial.

9

Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Trial (E1494).

Sparano JA, Lee S, Chen MG, Nazeer T, Einzig A, Ambinder RF, Henry DH, Manalo J, Li T, Von Roenn JH. Sparano JA, et al. J Clin Oncol. 2004 Apr 15;22(8):1491-500. doi: 10.1200/JCO.2004.08.195. J Clin Oncol. 2004. PMID: 15084622 Clinical Trial.

10

Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010.

Kaplan LD, Lee JY, Ambinder RF, Sparano JA, Cesarman E, Chadburn A, Levine AM, Scadden DT. Kaplan LD, et al. Among authors: sparano ja. Blood. 2005 Sep 1;106(5):1538-43. doi: 10.1182/blood-2005-04-1437. Epub 2005 May 24. Blood. 2005. PMID: 15914552 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

303 results

Search Page